Where I see patients (3)
Selected research
-
PET Imaging Using 89Zr Labeled StarPEG Nanocarriers Reveals Heterogeneous Enhanced Permeability and Retention (EPR) in Prostate Cancer.
Molecular cancer therapeutics
-
Impact of Posttreatment SPECT/CT on Patient Management During 177Lu-PSMA-617 Radiopharmaceutical Therapy.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
-
3D small-scale dosimetry and tumor control of 225Ac radiopharmaceuticals for prostate cancer.
Scientific reports
Clinical trials
Imaging Study of [89Zr]DFO-YS5 for Detecting CD46 Positive Malignancy in Multiple Myeloma
Defined as the rate of lesions with positive uptake when compared against 18F-fluorodeoxyglucose (FDG) PET/computed tomography (CT) positivity. Sensitivity estimated based on lesion level without considering the location of the le...
Recruiting
Magnetic Resonance (MR) Imaging With Hyperpolarized Bicarbonate (13C) to Measure Tissue pH in P...
The feasibility of a study will be determined by the ability to generate adequate signal to noise ratio to measure acidity (pH) in tumor or adjacent healthy tissue. This study will be considered successful if the 13C bicarbonate (...
Recruiting
PET Imaging Study of 89Zr-DFO-YS5 in Men With Prostate Cancer
For Cohort A, the optimal time point will be selected based on optimal maximun Standardized uptake value (SUVmax) of metastatic lesions, and ratio of SUVmax to blood pool. Due to the limited samples, the investigator will use all ...
Recruiting
Contact me
- Request appointment
- Refer a patient
- (415) 353-1968